Hong Il Yoo

Dr. Hong Il Yoo

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in The Korean Journal of Physiology & Pharmacology
Verified
Journal Article
Open access
PDF file
HYHong Il Yoo
Hong Il Yoo
YMYeon Hee Moon
Yeon Hee Moon
MKMin Seok Kim
Min Seok Kim
Yoo HI, et al. Korean J Physiol Pharmacol. 2016 Jan;20(1):53-62. http://dx.doi.org/10.4196/kjpp.2016.20.1.53

25 September 2014 in Journal of Dental Research
Verified
Journal Article
Closed access
JKJ.H. Kang
J.H. Kang
HKH.M. Ko
H.M. Ko
JMJ.S. Moon
J.S. Moon
HYHong Il Yoo
Hong Il Yoo
JJJ.Y. Jung
J.Y. Jung
SKS.H. Kim
S.H. Kim
Osteoprotegerin (OPG) is secreted by stromal and osteoblastic lineage cells and inhibits osteoclastogenesis by preventing the interaction of receptor activator of nuclear factor-κB ligand (RANKL) with receptor activator of nuclear factor-κB (RANK). In this study, the expression of OPG in osteoclasts themselves and its biological functions during osteoclastogenesis were investigated for the first time. OPG expression in vivo in the developing rat maxilla was examined by immunofluorescence analysis. OPG expression in osteoclasts during in vitro osteoclastogenesis was determined by reverse-transcription polymerase chain-reaction (RT-PCR), Western blot, and immunofluorescence staining. We determined the function of OPG produced by osteoclasts during osteoclastogenesis by silencing the OPG gene. The effects of OPG on bone-resorbing activity and apoptosis of mature osteoclasts were examined by the assay of resorptive pit formation on calcium-phosphate-coated plate and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining, respectively. In the immunofluorescence findings, strong immunoreactivities were unexpectedly seen in multinucleated tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts around the growing and erupting tooth germs in the rat alveolar bone. In vitro, OPG expression was significantly increased during the differentiation of osteoclasts from mouse bone-marrow-derived cells treated with a combination of macrophage colony-stimulating factor (M-CSF) and RANKL. Interestingly, it was found that OPG small interfering (si)RNA treatment during osteoclastogenesis enhanced the sizes of osteoclasts, but attenuated their bone-resorbing activity. Also, the increased chromosomal DNA fragmentation and caspase-3 activity in the late phase of osteoclastogenesis were found to be decreased by treatment with OPG siRNA. Furthermore, effects of OPG siRNA treatment on osteoclastogenesis and bone-resorbing activity were recovered by the treatment of exogenous OPG. These results suggest that OPG, expressed by the osteoclasts themselves, may play an auto-regulatory role in the late phase of osteoclastogenesis through the induction of apoptosis.

2 March 2017 in Journal of Molecular Histology
Verified
Journal Article
Closed access
PDF file
HYHong Il Yoo
Hong Il Yoo
EKEu-Gene Kim
Eu-Gene Kim
ELEun-Jin Lee
Eun-Jin Lee
SHSung-Young Hong
Sung-Young Hong
CYChi-Sun Yoon
Chi-Sun Yoon
DSDae-Young Song
Dae-Young Song

9 September 2015 in Journal of Dental Research
Verified
Journal Article
Closed access
SLS.Y. Lee
S.Y. Lee
HYHong Il Yoo
Hong Il Yoo
SKS.H. Kim
S.H. Kim
Tooth movement by application of orthodontic biophysical force primarily reflects the role of soluble molecules released from the periodontal ligament (PDL). Thus far, many factors have been reported to be involved in orthodontic tooth movement (OTM), but key molecules that orchestrate responses of periodontal tissues to biophysical force are still enigmatic. In this in vivo study, in which the upper first molars in rats were moved, differential display–polymerase chain reaction revealed that CC chemokine receptor 5 (CCR5) level was differentially increased during OTM. Strong immunoreactivity for CCR5 was found in the PDL undergoing force application. Moreover, the in vitro compression or tension force application to primary cultured human PDL cells increased the expression of CCR5 and CCR5 ligands. In vitro tension force on human PDL cells did not induce RANKL, an osteoclastogenesis-inducing factor, but did induce the upregulation of IL12, an osteoclast inhibitory factor, and osteoblast differentiation factors, including Runx2, which was attenuated under tension by CCR5 gene silencing whereas augmented with CCR5 ligands. In contrast, in vitro compression force did not induce the expression of osteoprotegerin, a decoy receptor for RANKL and Runx2, but did induce the upregulation of RANKL, which was attenuated under compression by CCR5 gene silencing. These results suggest that the CCR5–CCR5 ligands axis in PDL cells may play a crucial role in the remodeling of periodontal tissues and can be a therapeutic target for achieving efficient OTM.

1 October 2011 in Dentomaxillofacial Radiology
Verified
Journal Article
Closed access
MKM-S Kim
M-S Kim
SYS-J Yoon
S-J Yoon
HPH-W Park
H-W Park
JKJ-H Kang
J-H Kang
SYS-Y Yang
S-Y Yang
SKS-H Kim
S-H Kim
This study was performed in order to verify bifid mandibular canals revealed from panoramic radiographic results. 1000 panoramic radiographs from dental patients and the panorama, cone beam CT (CBCT) and micro-CT from 40 dry mandibles were examined for bifid mandibular canals. The results were confirmed by a stereoscopic and histological examination of the cross-sectioned mandibles. The prevalence of bifid canals detected from the panoramic radiographs was 0.038. The panoramic radiographs from one dry mandible showed two separate radiolucent mandibular canal-like structures delineated by radio-opaque lines. However, a stereoscopic and histological examination of a cross-section of the mandible showed that only one canal was a true canal containing neurovascular bundles: the other was false, reflecting merely a bony trabecular pattern. The presence of bifid mandibular canals determined by panoramic radiography should be judged with great caution in relation to dental surgery.

1 June 2018 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
YKYoung-Jung Kim
Young-Jung Kim
JYJi-Young Yoo
Ji-Young Yoo
OKOk-Soon Kim
Ok-Soon Kim
HKHan-Byeol Kim
Han-Byeol Kim
JRJunghwa Ryu
Junghwa Ryu
RWRan-Sook Woo
Ran-Sook Woo
The amyloid precursor protein (APP) is a key molecule in Alzheimer's disease. The prevailing view is that APP is initially transported to the plasma membrane as a full-length protein. Its localization at the cell surface can trigger downstream signaling and APP cleavage. Our previous work has shown that Neuregulin 1 (NRG1) has neuroprotective effects in an Alzheimer's disease model. In the present study, we examine whether NRG1 signaling is involved in APP expression and non-amyloidogenic processing in neuronal cells. Here we show that NRG1 increased the cell surface expression of APP without changing the total amount of APP mRNA or protein expression in SH-SY5Y cells and in rat primary cortical neurons. In addition, NRG1 significantly increased the levels of the secreted form of APP, sAPPα, in the conditioned media but did not change the expression of ADAM10 on the cell surface or in the cell lysates. Furthermore, we found that the protein level of NRG1 was reduced in the hippocampus of Alzheimer's disease (AD) patients. Our results demonstrate that NRG1 increased APP expression on the cell surface and sAPPα secretion into the media of neuronal cell cultures. Taken together, these results suggest a role for NRG1 in non-amyloidogenic processing.